BTGC's BioLon, a viscoelastic 1 percent solution of sodium hyaluronate for use in ophthalmic surgery, received marketing approval in India. Marketing partner Nirans Pvt. Ltd. has begun sales. The Iselin, N.J., company also said the...
BTGC's BioLon, a viscoelastic 1 percent solution of sodium hyaluronate for use in ophthalmic surgery, received marketing approval in India. Marketing partner Nirans Pvt. Ltd. has begun sales. The Iselin, N.J., company also said the...